• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec18
Femasys Inc. Obtains FDA Approval for FemVue Controlled Device
14:15
Nov15
Femasys released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 1.48 M and EPS of USD -0.4955
04:00
Femasys released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 729.39K (forecast USD 1.35M), actual EPS USD -0.1022 (forecast USD -0.115)
04:00
Nov3
Femasys Inc. Obtains FDA Approval to Commence Recruitment for FINALE Trial's Final Stage
13:30
Aug9
Femasys released FY2025 Semi-Annual earnings on August 8 (EST), actual revenue USD 750.53K, actual EPS USD -0.3878
03:00
Femasys released FY2025 Q2 earnings on August 8 (EST), actual revenue USD 409.27K (forecast USD 1.169M), actual EPS USD -0.16 (forecast USD -0.1625)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 729.39 K, Net Income -4.195 M, EPS -0.1022

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 409.27 K, Net Income -4.586 M, EPS -0.1587

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 341.26 K, Net Income -5.897 M, EPS -0.2344

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
12.200
+123.44%
+6.735
PFSA
0.1323
+93.70%
+0.064
AEHL
2.053
+81.72%
+0.920
CETX
3.178
+50.63%
+1.068
FLYE
7.670
+45.13%
+2.385
BRLS
2.300
+42.83%
+0.690
ZCMD
0.6343
+40.15%
+0.182
ONTF
8.028
+37.00%
+2.168
SCWO
2.265
+29.06%
+0.510
OCG
0.1070
+28.76%
+0.024
View More